Catalyst Vaccination A/S
Public limited companyCVR 45186660FrederiksbergActive
Catalyst Vaccination A/S is a public limited company, based in Frederiksberg, active in research and experimental development on natural sciences and engineering, founded in 2024. The company is new and has been registered for 2 years. The latest net result (2025) was a loss of DKK 2m. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesEmployees
- 3 more employees than a year earlier: 4 (07/2026) against 1 (07/2025).
Management and owners, last 24 months
- New in management: Anders Kaare Nørgaard (ceo, 01/11/2024), Søren Peder Tang Hansen (board member, 01/11/2024) and Christian Erik Drejøe (chair of the board, 01/11/2024) (+2).
- Stepped down: Anders Kaare Nørgaard (board member, 17/09/2025).
- New owners registered: MEDCED Capital Invest ApS (01/11/2024), Tang Hansen Holding ApS (01/11/2024) and Bitlinc ApS (26/11/2024) (+1).
Registrations, last 24 months
- 15/02/2025: Moved to Nordre Fasanvej 215, 2000 Frederiksberg
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
- 29/12/2024: Share capital changed from 400,000 DKK to 492,100 DKK
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2025–2025 · amounts in DKK thousand| 2025 | Change | |
|---|---|---|
| Revenue | not stated | – |
| Gross profit | −1,381 | – |
| Operating profit (EBIT) | −1,951 | – |
| Profit before tax | −1,951 | – |
| Net profit | −1,951 | – |
| Total assets | 578 | – |
| Equity | 526 | – |
| Liabilities | 52 | – |
| Cash and cash equivalents | 532 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
1 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/11/2024 – 31/12/2025 | 30/06/2026 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 68,974of 69,742 Better than 1% | No. 41,583of 69,964 Better than 41% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 258of 323 Better than 20% | No. 174of 329 Better than 47% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 16,353of 16,614 Better than 2% | No. 5,660of 16,661 Better than 66% |
| All companies of type A/S18,025 companies in the comparison | No. 17,468of 17,786 Better than 2% | No. 16,656of 18,024 Better than 8% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Catalyst Vaccination A/S−DKK 1.4m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Catalyst Vaccination A/S−DKK 2m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Catalyst Vaccination A/SDKK 526k
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Catalyst Vaccination A/S4
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- MEDCED Capital Invest ApS33.33%
- Tang Hansen Holding ApS33.33%
- Bitlinc ApS5%
- Tasc Holding ApS10%
Management
4 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Anders Kaare Nørgaard | CEO | 01/11/2024 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Søren Peder Tang Hansen | Board member | 01/11/2024 |
| Christian Erik Drejøe | Chair of the board | 01/11/2024 |
| Jens Hagenau | Board member | 17/09/2025 |
- Founders
- Ocean Process A/S
Former management (1)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Anders Kaare Nørgaard | Board member | 01/11/2024 | 17/09/2025 |
Signing rule: Selskabet tegnes af den samlede bestyrelse eller af direktøren i forening med bestyrelsesformanden
Address and production units
1 active production unitsNordre Fasanvej 215
2000 Frederiksberg
Frederiksberg Municipality · Postcode 2000
Other companies at the address (8)
- Sparrow Quantum ApSManufacture of computers and peripheral equipment
- Adcendo ApSResearch and experimental development on natural sciences and engineering
- Hemab ApSManufacture of pharmaceutical preparations
- Orbis Medicines ApSResearch and experimental development on natural sciences and engineering
- Minervax ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Catalyst Vaccination A/S | Nordre Fasanvej 215, 2000 Frederiksberg | 4 | 1030806693 |
Purpose
Virksomhedens formål er at eje immaterielle rettigheder vedrørende immunsystemet og at investere i udvikling og salg af software og farmaceutiske produkter baseret på disse rettigheder.
The purpose is quoted from the register in Danish.
Changes year by year
15 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20255 changesmanagement 2 · address 1 · ownership 1 · industry 1
- ManagementJens Hagenau appointed board member
- ManagementAnders Kaare Nørgaard stepped down as board member
- AddressMoved to Nordre Fasanvej 215, 2000 Frederiksberg
- OwnershipTASC HOLDING ApS registered as owner (10%)
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20249 changescapital 1 · ownership 3 · founded 1 · management 4
- CapitalShare capital changed from 400,000 DKK to 492,100 DKK
- OwnershipBITLINC ApS registered as owner (5%)
- FoundedRegistered as Catalyst Vaccination A/S
- ManagementAnders Kaare Nørgaard appointed board member
- ManagementAnders Kaare Nørgaard appointed ceo
- ManagementSøren Peder Tang Hansen appointed board member
- ManagementChristian Erik Drejøe appointed chair of the board
- OwnershipMEDCED Capital Invest ApS registered as owner (33.33%)
- OwnershipTang Hansen Holding ApS registered as owner (33.33%)
Related companies
Same industry in Frederiksberg
- Adcendo ApS49 employees
- Orbis Medicines ApS32 employees
- Minervax ApS28 employees
- Inprother ApS18 employees
- Acesion Pharma ApS16 employees
- Kost Studio ApS11 employees
Same people in management
- Resultmaker A/Svia Anders Kaare Nørgaard
- The Easycopy Company ApSvia Christian Erik Drejøe
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.